MarketPeel
Insider Trading Intelligence
PM

Philippe Menu

SOPH
CHIEF MEDICAL OFFICER · SOPHIA GENETICS SA · CIK 0002014308
FILING MIX · LIFETIME24%/76%
BUYS
4
SELLS
13
TOTAL VALUE
$150.1K
COMPANIES
1
ACTIVE SINCE
Mar 2026
HOLDINGS NOW
255,780
AVG SELL PX
$4.78
TRADE KIND
SHOWING 17 / 17
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 60 pending
Forward-return performance of every backtestable P/S trade by Philippe Menu, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+25.00%+3.63%+2.52%+1.22%+1.84%
14d12+8.33%+2.65%+3.99%-1.58%-1.88%
30d12(1 pending)+36.36%+0.76%+8.85%-7.30%-6.89%
60d12(11 pending)+100.00%-2.47%+12.51%-14.97%-14.97%
90d12(12 pending)
180d12(12 pending)
1y12(12 pending)
2y12(12 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SOPH · 255,780 shares · as of May 19, 2026
071,638143,276214,914286,552SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
2026
FLOW · 4 buys / 13 sellsCOVERAGE · 2 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
608$4.61$2.8K255,780May 19, 2026May 20, 2026
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
5,000$4.67$23.3K256,388May 12, 2026May 13, 2026
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
5,000$4.82$24.1K261,388Apr 27, 2026Apr 28, 2026
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
608$5.20$3.2K266,388Apr 20, 2026Apr 21, 2026
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
1,600$4.96$7.9K266,996Apr 14, 2026Apr 16, 2026
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
3,400$4.76$16.2K268,596Apr 13, 2026Apr 14, 2026
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
1,000$4.76$4.8K271,996Apr 13, 2026Apr 14, 2026
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
3,725$4.68$17.4K272,996Apr 10, 2026Apr 14, 2026
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
1,931$4.74$9.2K276,721Apr 9, 2026Apr 10, 2026
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
2,800$4.84$13.5K278,652Apr 8, 2026Apr 10, 2026
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
2,400$4.87$11.7K281,452Apr 7, 2026Apr 8, 2026
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
2,700$4.85$13.1K283,852Apr 6, 2026Apr 8, 2026
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
112,936112,936Apr 2, 2026Apr 3, 2026
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
164,671164,671Apr 2, 2026Apr 3, 2026
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
164,671164,671Apr 2, 2026Apr 8, 2026
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
112,936286,552Apr 2, 2026Apr 8, 2026
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
608$4.79$2.9K173,616Mar 19, 2026Mar 20, 2026
Other insiders · SOPH
Loading peer insiders…
About this filer
CIK 0002014308
ROLE
Chief Medical Officer
PRIMARY
SOPH
COMPANIES
1
ACTIVE SINCE
Mar 2026
MARKETPEEL · /INSIDER/0002014308DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback